Our transcriptomic study revealed an important upregulation of the Klk6 gene that encodes kallikrein-related peptidase 6, which is a biomarker of Alzheimer's disease (Diamandis et al., 2000). This evidence concerns the gene KLK6 and Alzheimer disease.